FDA ponders cardiovascular risks of ADHD drugs.
Young
Donna
D
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D000697:Central Nervous System Stimulants